These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32336655)

  • 1. Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.
    Siegler AJ; Mehta CC; Mouhanna F; Giler RM; Castel A; Pembleton E; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Sullivan PS
    Ann Epidemiol; 2020 May; 45():24-31.e3. PubMed ID: 32336655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis-to-need ratio in the fourth quarter of 2017, United States.
    Siegler AJ; Mouhanna F; Giler RM; Weiss K; Pembleton E; Guest J; Jones J; Castel A; Yeung H; Kramer M; McCallister S; Sullivan PS
    Ann Epidemiol; 2018 Dec; 28(12):841-849. PubMed ID: 29983236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.
    Sullivan PS; Mouhanna F; Mera R; Pembleton E; Castel AD; Jaggi C; Jones J; Kramer MR; McGuinness P; McCallister S; Siegler AJ
    Ann Epidemiol; 2020 Apr; 44():16-30. PubMed ID: 32088073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State same-sex marriage policies and pre-exposure prophylaxis implementation among men who have sex with men in the United States.
    Raifman J; Cheng DM; Skinner A; Hatzenbuehler ML; Mayer KH; Stein MD
    J Int AIDS Soc; 2023 Nov; 26(11):e26180. PubMed ID: 37997001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of national commissioning of pre-exposure prophylaxis (PrEP) on equity of access in England: a PrEP-to-need ratio investigation.
    Coukan F; Sullivan A; Mitchell H; Jaffer S; Williams A; Saunders J; Atchison C; Ward H
    Sex Transm Infect; 2024 Apr; 100(3):166-172. PubMed ID: 38508708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State-Level Discrimination Policies And HIV Pre-Exposure Prophylaxis Adoption Efforts In The US.
    Bonett S; Meanley S; Elsesser S; Bauermeister J
    Health Aff (Millwood); 2020 Sep; 39(9):1575-1582. PubMed ID: 32897779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-area spatial-temporal changes in pre-exposure prophylaxis (PrEP) use in the general population and among men who have sex with men in the United States between 2012 and 2018.
    Mouhanna F; Castel AD; Sullivan PS; Kuo I; Hoffman HJ; Siegler AJ; Jones JS; Mera Giler R; McGuinness P; Kramer MR
    Ann Epidemiol; 2020 Sep; 49():1-7. PubMed ID: 32951802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States.
    Siegler AJ; Bratcher A; Weiss KM; Mouhanna F; Ahlschlager L; Sullivan PS
    Ann Epidemiol; 2018 Dec; 28(12):858-864. PubMed ID: 30406756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.
    Sullivan PS; Giler RM; Mouhanna F; Pembleton ES; Guest JL; Jones J; Castel AD; Yeung H; Kramer M; McCallister S; Siegler AJ
    Ann Epidemiol; 2018 Dec; 28(12):833-840. PubMed ID: 30037634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to PrEP and other sexual health services for cisgender women in the United States: a review of state policy and Medicaid expansion.
    Chory A; Bond K
    Front Public Health; 2024; 12():1360349. PubMed ID: 38983260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From policy to practice: uptake of pre-exposure prophylaxis among adolescent girls and young women in United States President's Emergency Plan for AIDS Relief-supported countries, 2017-2020.
    Patel P; Sato K; Bhandari N; Kanagasabai U; Schelar E; Cooney C; Eakle R; Klucking S; Toiv N; Saul J;
    AIDS; 2022 Jun; 36(Suppl 1):S15-S26. PubMed ID: 35766572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Area-level HIV risk and socioeconomic factors associated with willingness to use PrEP among Black people in the U.S. South.
    Ransome Y; Bogart LM; Kawachi I; Kaplan A; Mayer KH; Ojikutu B
    Ann Epidemiol; 2020 Feb; 42():33-41. PubMed ID: 31899083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Correlation Between PrEP Use and Black:White Disparities in HIV Incidence in the Ending the HIV Epidemic Priority Jurisdictions.
    Bunting SR; Hunt B; Boshara A; Jacobs J; Johnson AK; Hazra A; Glick N
    J Gen Intern Med; 2023 Feb; 38(2):382-389. PubMed ID: 35678988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    Chan SS; Chappel AR; Maddox KEJ; Hoover KW; Huang YA; Zhu W; Cohen SM; Klein PW; De Lew N
    PLoS Med; 2020 Apr; 17(4):e1003072. PubMed ID: 32275654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Racism and HIV Pre-exposure Prophylaxis Use in the Nationwide US: A County-Level Analysis.
    Shi F; Mi T; Li X; Ning H; Li Z; Yang X
    J Racial Ethn Health Disparities; 2024 Aug; ():. PubMed ID: 39138800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review.
    Mayer KH; Agwu A; Malebranche D
    Adv Ther; 2020 May; 37(5):1778-1811. PubMed ID: 32232664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.
    Zhang C; McMahon J; Fiscella K; Przybyla S; Braksmajer A; LeBlanc N; Liu Y
    AIDS Patient Care STDS; 2019 Dec; 33(12):507-527. PubMed ID: 31821044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring HIV testing and pre-exposure prophylaxis information seeking by combining digital and traditional data.
    Johnson DC; Nobles AL; Caputi TL; Liu M; Leas EC; Strathdee SA; Smith DM; Ayers JW
    BMC Infect Dis; 2021 Feb; 21(1):215. PubMed ID: 33632140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variations of pre-exposure prophylaxis reversal and abandonment among United States counties.
    Dawit R; Goedel WC; Reid SC; Doshi JA; Nunn AS; Chan PA; Dean LT
    AIDS; 2024 Mar; 38(4):557-566. PubMed ID: 37976040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.